← back to search

Marc‐David Ruepp

King's College London · GB
Area of research
Molecular Biology · Neurology
Research interest
Research interests include RNA Research and Splicing, Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research, and RNA and protein synthesis mechanisms.
h-index
26
citations
2,935
works
98
NIH funding
primary concept
email

Recent publications

The Structured RNA-binding Domains and Condensation Capacity of FUS Shape its RNA-binding Landscape and Function
bioRxiv (Cold Spring Harbor Laboratory) 2026cited by 1position: lastdoi
Single-cell RNA-sequencing reveals early mitochondrial dysfunction unique to motor neurons shared across FUS- and TARDBP-ALS
Nature Communications 2025cited by 20position: middledoi
Cognition on the move: Examining the role of physical exercise and neurogenesis in counteracting cognitive aging
Ageing Research Reviews 2025cited by 13position: middledoi
Molecular basis of RNA-binding and autoregulation by the cancer-associated splicing factor RBM39
Nature Communications 2023cited by 35position: middledoi
HNRNPH1 regulates the neuroprotective cold‐shock protein RBM3 expression through poison exon exclusion
The EMBO Journal 2023cited by 27position: middledoi
G-quadruplexes control hepatitis B virus replication by promoting cccDNA transcription and phase separation in hepatocytes
Nucleic Acids Research 2023cited by 19position: middledoi
FUS-dependent liquid–liquid phase separation is important for DNA repair initiation
The Journal of Cell Biology 2021cited by 198position: middledoi
The phase separation-dependent FUS interactome reveals nuclear and cytoplasmic function of liquid–liquid phase separation
Nucleic Acids Research 2021cited by 126position: lastdoi
FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention
Nucleic Acids Research 2020cited by 113position: middledoi
Aberrant interaction of FUS with the U1 snRNA provides a molecular mechanism of FUS induced amyotrophic lateral sclerosis
Nature Communications 2020cited by 82position: lastdoi
miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis
Progress in Neurobiology 2020cited by 71position: middledoi
Human vtRNA1-1 Levels Modulate Signaling Pathways and Regulate Apoptosis in Human Cancer Cells
Biomolecules 2020cited by 40position: middledoi
Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy
Thyroid 2019cited by 79position: middledoi
Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization
Nature Communications 2019cited by 41position: middledoi
Phase Separation of FUS Is Suppressed by Its Nuclear Import Receptor and Arginine Methylation
Cell 2018cited by 666position: middledoi
Hypertonic Stress Causes Cytoplasmic Translocation of Neuronal, but Not Astrocytic, FUS due to Impaired Transportin Function
Cell Reports 2018cited by 61position: middledoi
CRISPR-Trap: a clean approach for the generation of gene knockouts and gene replacements in human cells
Molecular Biology of the Cell 2017cited by 53position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Stefan Reber · King's College London6 papers (2017–2025)Daniel Jutzi · King's College London6 papers (2017–2026)Jonas Mechtersheimer · King's College London5 papers (2017–2025)Oliver Mühlemann · University of Bern4 papers (2020–2021)Dorothee Dormann · Johannes Gutenberg University Mainz4 papers (2018–2026)Martino Colombo · University of Lausanne3 papers (2017–2023)Anny Devoy · King's College London3 papers (2020–2021)Eva Hedlund · Stockholm University3 papers (2017–2025) · 3 papers (2020–2021) · 2 papers (2020–2021) · 2 papers (2020–2023)Christoph Schweingruber · Stockholm University2 papers (2020–2025) · 2 papers (2020–2023)Michal Domanski · Rockefeller University2 papers (2017–2021)Julio Aguila Benitez · Karolinska Institutet2 papers (2017–2025)Saskia Hutten · Johannes Gutenberg University Mainz2 papers (2018–2026) · 2 papers (2021–2021)Sofia Pavlou · UK Dementia Research Institute1 papers (2023–2023)Andrea Du Preez · King's College London1 papers (2025–2025) · 1 papers (2020–2020)